Article
Priming of rat bone marrow-derived mesenchymal stem cells with curcumin induces an anti-inflammatory M2 phenotype in J774A.1 macrophage cell line.
BMC complementary medicine and therapies - 11 Dec 2025
Daryabor Gholamreza, Kheshtchin Nasim, Hashemi Seyede Zahra, Kahmini Fatemeh Rezaei, Gholijani Nasser
Abstract excerpt
CONTEXT: In recent years, several strategies have been used to enhance mesenchymal stem cells’ (MSCs) immunomodulatory and therapeutic potential. Curcumin (Cur), the main active component of turmeric from the Curcuma longa plant, might improve the effectiveness of MSCs. MATERIALS AND METHODS: Lipopolysaccharide (LPS)-stimulated J774.1 macrophages were treated with either Cur (10, 20, and 40 µM) or Rat bone...
Topics
Join the communities discussing this publication.
